Biogen first-quarter profit and revenue rose, buoyed by rising sales from its growth products, led by its drug to treat early Alzheimer’s.
About the Author
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
US News, Trends & Trusted Information
